|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/53 | (2006.01) |
| A61K 9/0019 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/0031 | (2013.01) | ||
| A61K 9/0043 | (2013.01) | ||
| A61K 9/02 | (2006.01) | ||
| A61K 9/06 | (2006.01) | ||
| A61K 9/0073 | (2013.01) | ||
| A61K 9/02 | (2013.01) | ||
| A61K 9/12 | (2006.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/06 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 9/12 | (2013.01) | ||
| A61K 9/70 | (2006.01) | ||
| A61K 9/2004 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/28 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 9/48 | (2013.01) | ||
| A61K 9/7023 | (2013.01) | ||
| A61K 31/53 | (2013.01) | ||
| A61K 9/0053 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3493809 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17752530.0 |
| Europos patento paraiškos padavimo data | 2017-08-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-06-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-08-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/045055 |
| Data | 2017-08-02 |
| (87) | Numeris | WO 2018/026894 |
| Data | 2018-02-08 |
| (30) | Numeris | Data | Šalis |
| 201662370673 P | 2016-08-03 | US | |
| 201662429649 P | 2016-12-02 | US |
| (72) |
AMATANGELO, Michael , US
HU, Xiaolan , US
THAKURTA, Anjan , US
|
| (73) |
Celgene Corporation ,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | ENASIDENIB FOR TREATMENT OF MYELODYSPLASTIC SYNDROME |
| ENASIDENIB FOR TREATMENT OF MYELODYSPLASTIC SYNDROME |